La Jolla Pharmaceutical Co. LJPC Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 4:16 PM

La Jolla Pharmaceutical Co. LJPC Company Overview

Stock Message Board http://investorshangout.com/search?q=LJPC&...mp;yt1=Go!

La Jolla Pharmaceutical Co. LJPC Current Price and Quotes
Last Price 0.0816
Previous Close 0.094 Open 0.095
Daily Range 0.095 - 0.0816 52wk Range 0.135 - 0.04
Volume 42,300 Dividend N/A
Average Vol (3m) 125,250 Yield N/A
La Jolla Pharmaceutical Co. LJPC
Company Information

4660 La Jolla Village Drive
Suite 1070
San Diego, CA 92122

Website: http://www.ljpc.com
Phone: 858-207-4264
Email: ir@ljpc.com

La Jolla Pharmaceutical Co. LJPC
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the development of therapies to treat human diseases that comprise cancer and chronic organ failure. Its lead product includes GCS-100, a clinical-stage inhibitor designed to sequester and eliminate circulating levels of galectin-3 for treating cancer with renal insufficiency and preventing chemotherapy toxicity, as well as for renal transplantation and cancer immunotherapy. The company is also developing LJPC-101, a subcu...

La Jolla Pharmaceutical Co. LJPC
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000920465
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: CA, USA
Year of Inc. 1989
Employees 3 a/o Mar 03, 2010
Company Officers/Contacts

George F. Tidmarsh President, CEO
Chester Zygmont CFO
Company Directors

George F. Tidmarsh
Saiid Zarrabian
Service Providers

Auditor/Accountant
Squar, Milner, Peterson, Miranda & Williamson, LLP
3655 Nobel Drive
Suite 450
San Diego, CA, 92122
United States

Legal Counsel
Ropes & Gray
1211 Avenue of the Americas
New York, NY, 10036
United States

Investor Relations Firm
Not Available

La Jolla Pharmaceutical Co. LJPC
LJPC Security Details

Share Structure

Market Value1 $2,487,676 a/o Sep 13, 2013
Shares Outstanding 30,486,228 a/o Jul 17, 2013
Float Not Available
Authorized Shares 12,008,000,000 a/o Jun 07, 2012
Par Value 0.01
Shareholders

Shareholders of Record 171 a/o Apr 01, 2013
Security Notes

Latest Addt'l Issue=7-96 2,000,000 shs at $5 by Robertson, Stephens & Co. et al.
New Issue=6-94 2,600,000 shs in Units (1 sh Com & 1 Warr 6-3-99) at $5 per Unit by D. Blech & Co., Inc.
Capital Change=shs decreased by 1 for 5 split Pay date=12/22/2005.
Capital Change=shs decreased by 1 for 100 split Pay date=04/15/2011.
Capital Change=shs decreased by 1 for 100 split. Pay date=02/17/2012.
Short Selling Data

Short Interest 11,412 (1,278.26%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

American Stock Transfer & Trust Company

La Jolla Pharmaceutical Co. LJPC Recent News

Sept 5, 2013 La Jolla Pharmaceutical Company to Present at the Rodman & Renshaw Annual Global Investment Conference on September 9, 2013
Aug 6, 2013 La Jolla Pharmaceutical Company Abstract Accepted for the American Society of Nephrology Kidney Week 2013
Jul 20, 2013 La Jolla Pharmaceutical Company Announces Second-Quarter 2013 Financial Results and Highlights Recent Corporate Progress
Jul 17, 2013 La Jolla Pharmaceutical Company Receives Orphan Designation From FDA
Jul 8, 2013 La Jolla Pharmaceutical Company Announces Start of Phase 2 Clinical Trial of GCS-100 for Chronic Kidney Disease
Jul 2, 2013 La Jolla Pharmaceutical Company Announces FDA Acceptance of IND for LJPC-501

La Jolla Pharmaceutical Co. LJPC Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - 8,125
Cost of Revenue - - - -
Gross Profit - - - 8,125
Operating Expenses

Research and Development 1,353 177 13 9,576
Sales, General and Admin. 9,386 2,097 3,915 7,193
Non-Recurring Items - - - -
Other - - - -
Operating Income (10,739) (2,274) (3,928) (8,644)
Income From Continuing Operations

Add'l Income/Expense Items 3,002 (9,274) 168 10
Earnings Before Interest and Tax (7,737) (11,548) (3,760) (8,634)
Interest Expense - - - -
Earnings Before Tax (7,737) (11,548) (3,760) (8,634)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,737) (11,548) (3,760) (8,634)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,737) (11,548) (3,760) (8,634)
Preferred Stock and Other Adjustments (780) (119) (466) -
Net Income Applicable to Common Shareholders (8,517) (11,667) (4,226) (8,634)

LJPC La Jolla Pharmaceutical Co. Research DD Guide

LJPC La Jolla Pharmaceutical Co. Stock Message Board http://investorshangout.com/search?q=LJPC&...mp;yt0=Go!
LJPC La Jolla Pharmaceutical Co. Stock Quote http://www.otcmarkets.com/stock/LJPC/quote
LJPC La Jolla Pharmaceutical Co. Stock Chart http://www.otcmarkets.com/stock/LJPC/chart
LJPC La Jolla Pharmaceutical Co. Company Info http://www.otcmarkets.com/stock/LJPC/company-info
LJPC La Jolla Pharmaceutical Co. Recent News http://www.otcmarkets.com/stock/LJPC/news
LJPC La Jolla Pharmaceutical Co. Financials http://www.otcmarkets.com/stock/LJPC/financials
LJPC La Jolla Pharmaceutical Co. Filings and Disclosure http://www.otcmarkets.com/stock/LJPC/filings
LJPC La Jolla Pharmaceutical Co. Short Sales http://www.otcmarkets.com/stock/LJPC/short-sales
LJPC La Jolla Pharmaceutical Co. Insider Disclosure http://www.otcmarkets.com/stock/LJPC/insider-transactions
LJPC La Jolla Pharmaceutical Co. Research Reports http://www.otcmarkets.com/stock/LJPC/research
LJPC La Jolla Pharmaceutical Co. Summary http://finance.yahoo.com/q?s=LJPC
LJPC La Jolla Pharmaceutical Co. Historical Prices http://finance.yahoo.com/q/hp?s=LJPC+Historical+Prices
LJPC La Jolla Pharmaceutical Co. Interactive Chart http://finance.yahoo.com/echarts?s=LJPC
LJPC La Jolla Pharmaceutical Co. Basic Chart http://finance.yahoo.com/q/bc?s=LJPC+Basic+Chart
LJPC La Jolla Pharmaceutical Co. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LJPC+Basic+Tech.+Analysis
LJPC La Jolla Pharmaceutical Co. Headlines http://finance.yahoo.com/q/h?s=LJPC+Headlines
LJPC La Jolla Pharmaceutical Co. Press Releases http://finance.yahoo.com/q/p?s=LJPC+Press+Releases
LJPC La Jolla Pharmaceutical Co. Company Profile http://finance.yahoo.com/q/pr?s=LJPC+Profile
LJPC La Jolla Pharmaceutical Co. Key Statistics http://finance.yahoo.com/q/ks?s=LJPC+Key+Statistics
LJPC La Jolla Pharmaceutical Co. Industry http://finance.yahoo.com/q/in?s=LJPC+Industry
LJPC La Jolla Pharmaceutical Co. Major Holders http://finance.yahoo.com/q/mh?s=LJPC+Major+Holders
LJPC La Jolla Pharmaceutical Co. Insider Transactions http://finance.yahoo.com/q/it?s=LJPC+Insider+Transactions
LJPC La Jolla Pharmaceutical Co. Insider Roster http://finance.yahoo.com/q/ir?s=LJPC+Insider+Roster
LJPC La Jolla Pharmaceutical Co. Income Statement http://finance.yahoo.com/q/is?s=LJPC
LJPC La Jolla Pharmaceutical Co. Balance Sheet http://finance.yahoo.com/q/bs?s=LJPC
LJPC La Jolla Pharmaceutical Co. Cash Flow http://finance.yahoo.com/q/cf?s=LJPC+Cash+Flow&annual
LJPC La Jolla Pharmaceutical Co. Nasdaq http://www.nasdaq.com/symbol/LJPC
LJPC La Jolla Pharmaceutical Co. Market Watch http://www.marketwatch.com/investing/stock/LJPC
LJPC La Jolla Pharmaceutical Co. Bloomberg http://www.bloomberg.com/quote/LJPC:US
LJPC La Jolla Pharmaceutical Co. Morningstar http://quotes.morningstar.com/stock/s?t=LJPC
LJPC La Jolla Pharmaceutical Co. Bussinessweek http://investing.businessweek.com/research/st...icker=LJPC
LJPC La Jolla Pharmaceutical Co. Barchart http://www.barchart.com/quotes/stocks/LJPC
LJPC La Jolla Pharmaceutical Co. OTC Short Report http://otcshortreport.com/index.php?index=LJPC
LJPC La Jolla Pharmaceutical Co. Investopedia http://www.investopedia.com/markets/stocks/LJPC/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Hyliion Class Action Deadline Nears for Investors

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Masimo's smartSET™ Revolutionizes Patient Monitoring

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Innventure Faces Major Lawsuit Over Misleading Investors

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Weifang's Cultural Resurgence: A Global Epigraphy Fest

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Voter Events by Valley Community Healthcare Aim to Empower

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....